Secretable HIV entry inhibitory peptides for therapy of HIV infection
EP2019134A1
Gene therapy of chronic granulomatous disease
AU2003208876A1
Methods for conducting site-specific dna recombination
DE10232196A1
In vitro or in vivo site-specific DNA recombination, useful e.g. for gene inactivation, using Cre recombinase that lacks heterologous protein-transduction domain
DE10207313A1
In vitro or in vivo site-specific DNA recombination, useful e.g. for gene inactivation, using Cre recombinase that lacks heterologous protein-transduction domain
DE10019075A1
Use of CD34 or a polypeptide derived therefrom as cell surface or gene transfer markers
